Endowed Chair, Cardiovascular Health and Risk Prevention
Cook Children's Medical Center
North Richland Hills, TX, United States
Brief Bio
Don P. Wilson, M.D., FNLA
Diplomate, American Board of Clinical Lipidology
Endowed Chair, Pediatric Cardiovascular Health and Risk Prevention
Pediatric Endocrinology and Diabetes
Cook Children’s Medical Center
Fort Worth, Texas
don.wilson@cookchildrens.org
A pediatric endocrinologist by training, Dr. Don Wilson has devoted the past 20 plus years of his career to cardiovascular health and risk prevention in children and adolescents. Recognizing that CVD is the leading cause of morbidity and mortality in the U.S. and developed countries, Dr. Wilson developed 3 unique pediatric cardiovascular health and risk prevention programs as a member of the academic faculty of Texas A&M University, University of Arizona, and Texas Christian University. Currently he serves as the Endowed Chair of the Pediatric Cardiovascular Health and Risk Prevention Program at Cook Children's Medical Center in Fort Worth Texas. He serves as Associate Editor for the Journal of Clinical Lipidology, the Current Atherosclerosis Reports and EndoText. In addition to being Associate Editor, Dr. Wilson is a reviewer for the Journal of Clinical Lipidology, and over 20 other professional journals, including Atherosclerosis, Journal of Pediatrics, Pediatrics, Clinical Pediatrics, Diabetes/Metabolism Research and Reviews, and International Journal of Obesity. He has authored over 150 peer-reviewed publications, including many which focus on CVD risk burden, prevention, and treatment in children with genetic and acquired disorders of lipid metabolism. Dr. Wilson has served as Guest Editor for 5 thematic peer-reviewed publications covering a wide variety of topics related to CVD prevention and treatment in children and adolescents. He also co-authored several book chapters. As an expert in the field of clinical lipidology, Dr. Wilson has given numerous invited oral presentations and written editorial comments for leading peer-reviewed lipid/lipoprotein and CVD related journals.
Disclosure information not submitted.
MC02-02 - Management of Insulin Resistance and Obesity
Monday, June 15, 2026
3:30 PM - 4:15 PM CT